The data shows that the mean scores on both SDQ scales are within the ranges considered by Mellor [ 26] to be "normal" (see http://www.sdqinfo.org), nevertheless the scores for the Total Difficulties scale extended across the "normal", "borderline" and "abnormal" classifications, as defined in the scoring instructions.
For the purposes of this study, the two deviant classifications (borderline and clinical) were grouped together and further relabeled as "at risk of" (cutoff criteria for each scale/subscale are presented in Table 2).
The SDQ classification into borderline and abnormal for some scales was affected by the method (OR = 0.36-1.55).
Rotatable bonds of a conformation are colored according to their classification into usual, borderline and unusual torsion angles, using the list of allowed angles from the corresponding patterns.
Scoring was performed by at least two investigators (in very few borderline cases, classification of immunostaining required additional investigators and was based on the consistency of the majority of them).
Lugol's staining demonstrated the borderline and the stain grade, while the Paris classification distinguished the invasive from noninvasive lesion.
● clustering and classification.
Chapter 17 Summary And Classification.
To deal with this problem, we classified sites, lots, and technicians according to whether their observed false positive rates were ≤0.5%, >0.5% and <1.0%, or ≥1.0%, representing acceptable, borderline, and clearly unacceptable rates, and then controlled for these classifications.
The results were significant for the syndromes of Attention Problems at 7 years [odds ratio (OR) = 3.30, 95% CI, 1.21 12.54] and Anxious/Depressed at 4.8 years (OR = 8.14, 95% CI, 1.21 54.94), showing that higher cord adducts were associated with increased likelihood of borderline or clinical classification on Anxious/Depressed and Attention Problems.
Based on the World Health Organization (WHO) histological classification for tumors, 3 grades have been described for cystic neoplasms of the pancreas: benign, low-grade malignant (borderline), and malignant (carcinoma in situ and invasive cancer).
